Serum Institute of India, which also manufactures the Covishield vaccine currently administered in the country. Apart from India, the vaccine manufacturer has asked Indonesia and the Philippines to allow emergency use of its Covid-19 vaccine, called Covovax.
The Novavax two-dose shot is made with lab-grown copies of the spike protein that coats the coronavirus. That’s very different than other widely used vaccines that deliver genetic instructions for the body to make its spike protein.
In June, Novavax announced the vaccine had proved about 90% effective against symptomatic Covid-19 in a study of nearly 30,000 people in the US and Mexico.